Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopecia

Abstract

Platelet-rich plasma (PRP) is widely used in dermatology. Its use is part of the global market for PRP that is expected to exceed $4 billion in the next 10 years. 1 Jones I.A. Togashi R.C. Vangsness Jr., C.T. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med. 2018; 11: 558-565 Crossref PubMed Scopus (27) Google Scholar Factors driving the market include PRP's theoretical scientific basis, demonstrated safety, ease of use, critical need for new therapies, hopes of patients, and predominantly persuasive advertising. 1 Jones I.A. Togashi R.C. Vangsness Jr., C.T. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med. 2018; 11: 558-565 Crossref PubMed Scopus (27) Google Scholar PRP is costly, usually requires multiple treatments, and is not covered by insurance in most cases. 1 Jones I.A. Togashi R.C. Vangsness Jr., C.T. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med. 2018; 11: 558-565 Crossref PubMed Scopus (27) Google Scholar